Biovitrum reports 52% increase in revenue in the 2009 first half

The Swedish speciality pharmaceutical company, Biovitrum AB, said revenue before licensing income increased by 52% to SEK 675.1 million in the 2009 first half as the company expanded its pharmaceutical sales beyond the Nordic region.